VTVT
VTVT
NASDAQ · Biotechnology

Vtv Therapeutics Inc- Cl A

$20.69
-0.78 (-3.63%)
As of Nov 13, 2:20 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +62.2% upside
Low Target $24.17
Average Target $33.56
High Target $46.23
Current Price $20.69
Current
$20.69
Target
$33.56
$24.17 $33.56 avg $46.23
Scenario Analysis
Bear Case
$24.17
16.8%
Low target
Base Case
$33.56
+62.2%
Avg target
Bull Case
$46.23
+123.4%
High target
Risk/Reward
7.3x
Highly favorable
Price in Context
52-Week High
$44.00
-53.0% from high
52-Week Low
$21.72
+-4.7% from low
Target vs 52W High
$33.56
-23.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%